Pharma Tips

Mylan Inc to acquire Famy Care's businesses for $800 mn

By: Pharma News | Views: 867 | Date: 05-Feb-2015

Mylan Inc will acquire certain businesses of Mumbai-based Famy Care Ltd, a specialty women's health care company, for a total consideration of $800 million (over Rs 4,940 crore).

Mylan Inc to acquire Famy Care's businesses for $800 mn

Mylan Inc will acquire certain businesses of Mumbai-based Famy Care Ltd, a specialty women's health care company, for a total consideration of $800 million (over Rs 4,940 crore).

Mylan Famycare

US-based Mylan Inc through its Indian subsidiary Mylan Laboratories has signed a definitive agreement to acquire certain female health care businesses from Famy Care Ltd, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs), Mylan Inc said in a statement.

The deal envisages payment of $750 million in cash plus additional contingent payments of up to $50 million, it added.

"The acquisition will build on Mylan's existing partnerships with Famy Care in North America, Europe and Australia, and provide Mylan with an enhanced and now vertically integrated platform that will accelerate the company's growth in the important global women's health care space," the company said.

Mumbai-based Famy Care focuses on female reproductive health care and is world leader in supplying a wide range of contraceptive pills, injectables and devices.

It sells products in over 100 countries. It had attracted PE investment from AIF Capital, one of Asia's long-standing independent private equity firms.

Mylan said the acquisition of the Famy Care's businesses will make it a hormonal contraceptives leader in high-growth emerging markets around the world.

The transaction is expected to close in the second half of 2015, subject to regulatory approvals and certain closing conditions. In 2008, Mylan had formed a partnership with Famy Care, significantly enhancing its presence in the women's health care segment in the US and other developed markets.

Commenting on the development, Mylan CEO Heather Bresch said: "With today's acquisition, we are building on this successful partnership and further accelerating our global growth in this important therapeutic area."

As part of the deal, 900 employees of Famy Care will become a part of Mylan, he added.

Famy Care Non-executive Chairman JP Taparia said: "We foresee significant opportunities in the women's health care business across developed and emerging markets, and the proposed transaction provides an opportunity for our team to capture the opportunity in an even more effective manner."

Shareholders of Famy Care will evaluate and pursue other opportunities in the residual Famy Care business outside of women's health care segment, Taparia added.

Mylan said more than 15 per cent of the world's women using oral contraceptive pills "today use a Famy Care product".

Previous Page Next Page

People Searching On This Page:
  • maylan pharma

Related Pages


Piramal Enterprises acquires Mallinckrodt's Pharma Products for $203 million

Piramal Enterprises acquires Mallinckrodt's Pharma Products for $203 million

News | Pharma Companies
Date:
31-Jan-2017  Views: 689

Ajay Piramal led Piramal Enterprises has acquired a portfolio of anti-spasticity and pain management drugs from US based drug maker Mallinckrodt in an ...
Abbott to Acquire Alere, becoming leader in point of care testing

Abbott to Acquire Alere, becoming leader in point of care testing

News | Pharma Companies
Date:
05-Feb-2016  Views: 1133

Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today a definitive agreement for Abbott to acquire Alere, significantly advancing Abbott's glo ...
Alkem Labs to launch $210 mn IPO in December

Alkem Labs to launch $210 mn IPO in December

News | Pharma Companies
Date:
26-Nov-2015  Views: 2010

Drug manufacturer Alkem Laboratories Ltd is set to launch an initial public offering (IPO) worth nearly $210 million by the second week of December, t ...
Indian Cabinet approve $750 mn investment by Mylan in India

Indian Cabinet approve $750 mn investment by Mylan in India

News | Pharma Companies
Date:
26-Nov-2015  Views: 14272

"The union cabinet, chaired by Prime Minister Narendra Modi, has approved $750-million FDI in Mylan Laboratories Ltd by Mylan Group through equity sha ...
Teva Offers to acquire Mylan for $40 billion in cash, stock

Teva Offers to acquire Mylan for $40 billion in cash, stock

News | Pharma Companies
Date:
30-Apr-2015  Views: 5710

Israeli pharma major Teva on Tuesday offered to acquire US-based Mylan in a deal estimated to be around $40 billion in cash and stock. ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

43  + 6 =     
Comments
People Searched About:
Maylan Pharma   |  
Google : 32 times | Yahoo : 12 times | Bing : 5 times |